论文部分内容阅读
目的评价新柏氏TCT膜式液基超薄细胞学对宫颈癌及宫颈癌前病变的诊断价值,探讨宫颈癌的防治方案。方法对2007年7～12月在本院行新柏氏TCT液基超薄细胞学检测9788例进行回顾性分析,对TBS分级系统细胞学阳性者进行阴道镜下活检对比。结果宫颈细胞学阳性者415例,阳性率为4.24%;HPV感染177例。在细胞阳性者中LSIL52例,HSIL146例,宫颈癌49例,ASCUS20例,ASC-H127例。在阳性例中352例有宫颈外观描述,分为宫颈光滑组、轻糜组、中糜组和重糜组,分占总阳性率的9.94%,32.95%,25.57%和31.53%。结论TCT和TBS系统能有效反映宫颈病变情况,和HPV检测结合有利于宫颈癌的早期发现。
Objective To evaluate the value of TCT membrane-based ultrathin cytology in the diagnosis of cervical cancer and cervical precancerous lesions and to explore the prevention and treatment of cervical cancer. Methods A retrospective analysis was performed on 9788 cases of neoboger TCT liquid-based ultra-thin cytology in our hospital from July to December in 2007, and colposcopy biopsy was performed on those with positive TBS grading system cytology. Results 415 cases of cervical cytology were positive, the positive rate was 4.24%; HPV infection in 177 cases. LSIL 52 cases, HSIL 146 cases, cervical cancer 49 cases, ASCUS 20 cases, ASC-H127 cases were positive in cell-positive cases. Among the positive cases, 352 cases had cervical appearance description, which were divided into smooth cervical group, mild miliary group, moderate mistic group and heavy mistic group, accounting for 9.94%, 32.95%, 25.57% and 31.53% of the total positive rate. Conclusion The TCT and TBS systems can effectively reflect the cervical lesions, combined with HPV testing is conducive to the early detection of cervical cancer.